All News

TURNING THEORY INTO ACTION:REAL-WORLD EVIDENCE DRI

Historically, it has taken at least 10 years for a new drug to complete the journey from initial dis
Read More

Johnson & Johnson, AbbVie, Teva and Endo face $50B

Before COVID-19 hit, daily headlines swirled around pharma’s role in the opioid crisis and lawsuits
Read More

Q&A with Acting FDA Commissioner Janet Woodcock on

The U.S. Food and Drug Administration (FDA) embarked on a data and IT infrastructure modernization p
Read More

J&J, Teva and Other Opioid Drugmakers Face $50 Bil

The governments of several large California counties and one city filed the lawsuit against the four
Read More

Clinical Catch-Up: April 12-16

AstraZeneca announced that its Farxiga (dapagliflozin) failed to hit the endpoints in its Phase III
Read More

Adagio Raises $336 Million to Support Development

Adagio Therapeutics announced today it has completed a $336 million Series C financing round, which
Read More

J&J Vaccine: Know the Signs of Rare Blood Clot

While U.S. federal government experts probe potential risks of the Johnson & Johnson vaccine, what d
Read More


;